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Abstract
Materials and Methods
Fig.1 Viral RNA concentration and CT values for killed and live vaccines 
Live and killed virus vaccines
Four commercial killed virus vaccines and four live virus vaccines were obtained 
form company A, B, C and D. We also prepared a prototype  killed virus vaccine 
form the classical virus strain STC in our lab.
RNA extraction for live and killed virus vaccines
1ml of chloroform was mixed with 0.5 ml of vaccine suspensions and then 
incubated it for 10 min at room temperature.  The mixture was then centrifuged 
at 4000 RPM for 15 minutes. The upper aqueous layer was taken for RNA 
extraction by Trizol and RNeasy methods  following the manufacturer 
instructions. The RNA concentration was then measured by nano drop
spectrophotometer.
Real time RT-PCR for the killed and live virus vaccines
The real-time RT-PCR was performed on 7500 RT-PCR system (Applied 
Biosystems) both for killed and live virus vaccines. One step RT-PCR sensimix
kit obtained from Quantace was used for RT-PCR master mix. The 743b.p 
primer for conserved VP2 region of IBDV(1)  was used. The primer
concentration was adjusted to 25 uM. The reaction profile was as follow: 45oC 
for 30 minutes, 95 oC for 10minutes, 95 oC for 15 seconds, 60 oC for 32 
seconds and 72 oC for 1 minute.(2)
In this study we standardized  a method for viral RNA extraction from commercially available killed and live vaccines against infectious bursal disease virus (IBDV). We 
also used a prototype strains  (STC) of know titer to prepare killed vaccine in our laboratory.  We used the same live virus to develop a  standard curve . We were able to 
show the differences in  RNA content  between the different vaccines.
Results and Discussion
In case of killed virus vaccine we obtained 123.11ng/ul of RNA concentration for 
Vaccine- 2 (vac-2 )  77.43 , 58.32 and 52.77 ng/ul for vaccines 1(vac-1) , 
vaccines-3(vac-3 and vaccine -4 (vac-4) respectively. The prototype vaccine 
STC gave higher RNA concentration of 378.38 ng/ul due to the fact that we  
used  higher concentration of viral RNA (107 EID50) for vaccine preparation. 
(Fig.1)
Where as in case of live virus vaccines we observed 1314.42 ng/ul ,1025.76 
,820.72  and 780.31 ng/ul  of viral RNA   concentrations  for live virus vaccines 
C, B, A and vaccine D respectively. (Fig.1). The Fig.3 &4 represent the melting 
curve and amplification plot for chloroform-Trizol LS extracted viral RNA and 
Fig.5 & 6 represent the Chloroform-RNeasy extracted RNA from killed vaccines.
Form  our data we can deduce  that different manufacturer use different virus 
concentration for vaccine preparation. This may be the fact that different 
vaccines induces varied level of protection against IBDV infection in the  field 
conditions. This varied level of protection may also be attributed to the type of 
strains used for the vaccine preparation. 
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Introduction
Vaccines provide protection against a potential threatening pathogen by 
inducing an immune response against the pathogen. If the titer of the pathogen 
in the vaccine is not adequate the response might not be sufficient to protect 
the animal. The objective of this study was to develop a method to extract the 
agent (viral RNA) from different commercially available killed and live vaccines  
against IBDV. We developed two different methods for viral extraction and 
found that modified chloroform-Trizol method of extraction gives better viral 
RNA concentration yield and real-time  RT-PCR results as compared with 
modified chloroform-RNeasy method of RNA extraction














Fig.3  Melting Curve Analysis for killed 
vaccines with Chloroform-Trizol LS extracted 
RNA
Fig.4 Real-Time RT-PCR Amplification plot 
for killed vaccines with Chloroform-Trizol LS 
extracted RNA
Real-Time RT-PCR for Killed Vaccines
Sample I.D. ng/ul C.T. Value
1 IBDV Killed Vaccine (Vac-1) 77.43 27.38
2 IBDV Killed Vaccine (Vac-2) 123.11 30.44
3 IBDV Killed Vaccine (Vac-3) 58.32 25.48
4 IBDV Killed Vaccine (Vac-4) 52.77 30.17
5 STC killed virus (Vac-5) 378.38 34*
Real-Time RT-PCR for Live Vaccines
i Live Vaccine (A) 820.72 33
ii Live Vaccine (B) 1025.76 34
iii Live Vaccine (C) 1314.42 28
iv Live Vaccine (D) 780.31 32
v STC Live virus 991.4 21.1**
* 1:10 dilution of RNA
** Positive control
Fig.2 Standard Curve based on STC with SYBR® Green 
Fig.5 Melting Curve Analysis for killed  
vaccines with Chloroform-RNeasy extracted 
RNA
Fig.6 Real-Time RT-PCR Amplification plot 
for killed vaccines with Chloroform-RNeasy 
extracted RNA
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